Overexpression of LCN2 in breast cancer, accompanied by increased expression of the key EMT transcription factor Slug, upregulated the mesenchymal markers vimentin and fibronectin while downregulated the epithelial marker E-cadherin, increasing the invasiveness of the tumor. This evidence concerns the gene LCN2 and breast carcinoma.